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ABSTRACT Pemphigus is an autoimmune bullous disease, and although several diag-
nostic methods are now in use indirect immunofluorescence (IIF) is still considered an 
important tool for diagnosing pemphigus because of its convenience, repeatability, 
and reduced pain for patients. The goal of the present study was to evaluate the diag-
nostic value of IIF on normal human skin (NS), monkey esophagus (ME), and salt-split 
skin (SS) for better diagnosis of pemphigus. Clinical data of 70 patients with pemphi-
gus and 56 control were collected. IIF on NS, ME, and SS were assessed separately by 
observing fluorescein deposition and comparing its differentiation to different kinds 
of pemphigus and its sensitivities and specificities to different substrates. Intercellular 
deposition of IgG was visible when IIF on NS, ME, and SS were positive in patients 
with pemphigus. Their corresponding sensitivities and specificities were 30.0%, 84.3%, 
and 70.0% and 96.4%, 96.4%, and 94.6%, respectively. The differences in sensitivity 
were statistically significant between NS and ME and between NS and SS (P<0.001) 
and the specificities among the three substrates were not statistically significantly dif-
ferent (P>0.05). As for different types of pemphigus, the sensitivities between NS and 
ME and between NS and SS were statistically significantly different in both Dsg1- and 
Dsg3-positive and only Dsg1-positive patients with pemphigus (P<0.01); the sensitivi-
ties between NS and ME were statistically significantly different only in Dsg3-positive 
patients with pemphigus (P<0.001); there were no statistically significant differences 
between ME and SS. We therefore propose that ME is a good substrate for pemphigus 
diagnosis with higher sensitivity and superior to NS, particularly for patients with anti-
Dsg3 antibodies. SS is a good alternative substrate to ME with almost identical higher 
sensitivities and specificities for diagnosis of pemphigus.
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INTRODUCTION
Pemphigus is a potentially life-threatening auto-
immune bullous disease, characterized by autoanti-
bodies to the desmosomal proteins (desmoglein 1 
and 3) that connect keratinocytes. Pemphigus can 
be divided into different types According to clinical 
manifestations and autoantibodies, pemphigus can 
be divided into different groups. Pemphigus vulgaris 
(PV) and pemphigus foliaceus (PF) are the two main 
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types, and less common variants include paraneo-
plastic pemphigus and IgA pemphigus. Although the 
gold standard for diagnosing pemphigus is the de-
tection of autoantibodies by direct immunofluores-
cence (DIF) and enzyme-linked immunosorbent assay 
(ELISA) systems (1), indirect immunofluorescence (IIF) 
is still considered an important tool for diagnosing 
pemphigus because of its convenience, repeatability, 
and reduced pain for patients.
Previous studies have suggested that normal hu-
man skin (NS) and monkey esophagus (ME) can be 
good substrate to detect pemphigus antibodies with 
IIF, and monkey esophagus has been largely accept-
ed as the optimal substrate. But monkey esophagus 
is not easy to acquire, although commercial kits of ME 
substrate are already available. It is however expen-
sive and cannot by widely used. Herein we evaluated 
the diagnostic value of IIF on three different kinds 
of substrates including normal human skin, monkey 
esophagus, and salt-split skin (SS) for diagnosing 
pemphigus.
Table 1. The sensitivities of indirect immunofluorescence (IIF) on different substrates
Group No. NS ME SS χ2 P value
Pemphigus Dsg1 and Dsg3 both 
positive
25 9 (36.0%) 23 (92.0%) 19 (76.0%) 19.1 <0.001
Only Dsg1 positive 33 9 (27.3%) 24 (72.7%) 22 (66.7%) 16.3 <0.001
Only Dsg3 positive 12 3 (25.0%) 12 (100%) 8 (66.7%) 15.3 <0.001
All 70 21 (30.0%) 59 (84.3%) 49 (70.0%) 46.8 <0.001
Control Subepidermal bullous 
diseases
26 1 2 2
Eczema 15 1 0 1
Healthy people 15 0 0 0
All 56 2 2 3
NS: normal human skin; ME: monkey esophagus; SS: salt-split skin
χ
Figure 1. Different patterns of fluorescein deposition with indirect immunofluorescence (IIF) on different substrates. (A) A 
whole layer of intercellular deposition of IgG on stratum spinosum was visible with IIF on normal human skin (NS) in pem-
phigus vulgaris. (B) Intercellular deposition of IgG on the upper stratum spinosum was visible with IIF on NS in pemphigus 
foliaceus. (C) Intercellular deposition of IgG on stratum spinosum was visible with IIF on salt-split skin (SS) in pemphigus 
foliaceus. (D) No fluorescein deposition of IgG on the stratum spinosum and the basement membrane zone was visible with 
IIF on NS in controls. (E) Intercellular deposition of IgG with IIF on monkey esophagus (ME) in pemphigus vulgaris.
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PATIENTS AND METHODS
This study was performed in adherence with the 
Declaration of Helsinki and guidelines of local ethics 
committees of the Institute of Dermatology, Chinese 
Academy of Medical Sciences, and Peking Union 
Medical College. Informed consent was provided by 
all patients and controls.
The sera from 70 newly-diagnosed patients with 
pemphigus and 56 control individuals (without pem-
phigus) were tested. The pemphigus group consisted 
of 43 men and 27 women aged 15-97 years (mean: 
48.4 years). Pemphigus was diagnosed based on the 
clinical, histologic, DIF, and ELISA results for anti-
Dsg1/anti-Dsg3. The patients were classified into 
three groups according to the results of ELISA for 
anti-Dsg1/anti-Dsg3 antibodies. Out of the 70 pa-
tients with pemphigus, 37 had PV (25 cases positive 
for both Dsg1 and Dsg3 and 12 cases positive for only 
Dsg3) and 33 patients had PF (only Dsg1 positive). 
The 56 control cases without pemphigus included 
26 patients with autoimmune subepidermal bullous 
diseases, 15 patients with chronic eczema, and 15 
healthy persons. ELISA was performed to detect anti-
Dsg1 and anti-Dsg3 antibodies, and all control cases 
were negative.
Desmoglein 1 and 3 ELISAs were performed in ac-
cordance with the manufacturer’s instructions (MBL, 
Nagoya, Japan). The sera were diluted to 1:100 and 
the cutoff index value was 20.0 as recommended by 
the instructions on the kit. SS was made with nor-
mal human skin through incubation in 1.0 M sodium 
chloride, mounted in Tissue-Tek O.C.T (Sakura Finetek, 
USA), and then cut into frozen sections, as previously 
described (2). IIF was conducted on NS and SS using 
routine methods. The skin samples were collected 
from normal skin remaining from plastic surgery and 
were embedded, cut into frozen sections, and then 
stained with fluorescein isothiocyanate-labled poly-
clonal goat anti-human IgG antibodies (ZSbio, Beijing, 
China). IIF was performed on ME with kits utilizing the 
standard technique (EUROIMMUN AG, Lübeck, Ger-
many). The sera of IIF were diluted to 1:10. The results 
were examined independently by two of the authors 
to determine whether the intercellular deposition of 
IgG was positive. The data were analyzed using SPSS 
23.0 software package (IBM, Chicago, USA). Descrip-
tive statistics were summarized as number, percent-
age, and mean. The numerical data were assessed us-
ing the chi-square test or Fisher’s exact test. P values 
less than 0.05 were considered significant, indicated 
by an asterisk in the figures. 
RESULTS
The intercellular deposition of IgG was visible with 
IIF on NS, ME, and SS and was positive in patients with 
pemphigus (Figure 1); the corresponding sensitivi-
ties of the substrates were 30.0%, 84.3%, and 70.0%, 
respectively (Table 1), while the specificities were 
96.4%, 96.4%, and 94.6%, respectively. The differenc-
es in sensitivity between NS and ME and between NS 
and SS were statistically significant (P<0.001) and the 
differences in specificity among the three substrates 
were not statistically significant (P>0.05), which 
means ME and SS were superior to NS as substrates 
for pemphigus. As for different types of pemphigus, 
the differences in sensitivity between NS and ME and 
between NS and SS were statistically significant in 
both Dsg1- and Dsg3-positive and only Dsg1-positive 
patients with pemphigus (P<0.01); only in Dsg3-posi-
tive pemphigus patients the difference in sensitivity 
between NS and ME statistically significant (P<0.001) 
was found, which showed that ME is better than NS as 
substrate. However, there were no statistically signifi-
cant differences between ME and SS, which indicates 
that SS could be a good alternative substrate to ME 
with almost identical sensitivity in pemphigus diag-
nosis (Table 2). 
DISCUSSION
Serological diagnostic tools with enhanced sen-
sitivity and specificity have become available due to 
the development of modern diagnosis techniques for 
autoimmune bullous diseases. Nonetheless, IIF is still 
considered a well-established method for detecting 
circulating autoantibodies in patients with pemphi-
gus. Finding the optimal substrate is critical to im-
proving the diagnostic performance of this tool.
Table 2. Statistical results of sensitivities of indirect immunofluorescence (IIF) on different substrates





χ2 P value χ2 P value χ2 P value χ2 P value
NS IIF vs. ME IIF 42.1 <0.001 14.7 <0.001 13.6 <0.001 <0.001
NS IIF vs. SS IIF 22.4 <0.001 8.1 0.004 10.3 0.001 0.1
ME IIF vs. SS IIF 4.05 0.04 1.3 0.25 0.29 0.6 0.09
NS: normal human skin; ME: monkey esophagus; SS: salt-split skin
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In 1964, Beutner and Jordon (3) first applied IIF to 
detect the skin autoantibodies in the sera of patients 
with PV. In 1969, Stephen et al. (4) used human skin 
as substrate to detect pemphigus antibodies, and its 
sensitivity was superior to that of rabbit esophagus. 
Feibelman et al. (5) demonstrated that ME is a more 
sensitive substrate than guinea pig esophagus. Har-
man et al. (6) compared the sensitivity of NS and ME 
as IIF substrates and found that for patients with only 
anti-Dsg3 antibodies, the sensitivity was the highest 
with ME, which is in accordance with our data. How-
ever, in contrast to our results, they reported that for 
patients with only anti-Dsg1 antibodies the sensitiv-
ity was the highest with NS. Our study found that 
ME or SS were a better IIF substrate than NS and had 
higher sensitivity in patients regardless of whether 
they were Dsg1- or Dsg3-positive. When ME was used 
as the substrate, its sensitivity was higher in patients 
with only anti-Dsg3 antibodies than that in patients 
with only anti-Dsg1 antibodies. This difference could 
be attributed to the insufficient number of cases or 
ethnic differences. We also compared SS with ME and 
NS the first time, and the high sensitivity and specific-
ity of SS indicated that SS could be a good alternative 
substrate for pemphigus diagnosis; potentially due to 
the exposure of antigenic epitopes after the cleavage 
of the skin.
CONCLUSION
Monkey esophagus is a good substrate for pem-
phigus diagnosis with higher sensitivity and superior 
to NS, particularly for patients with anti-Dsg3 anti-
bodies. Moreover, SS is a good alternative substrate 
to ME with almost identical higher sensitivities and 
specificities for diagnosis of pemphigus.
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